AstraZeneca exceeded market expectations in its second-quarter earnings report. The British pharmaceutical firm has also upgraded its guidance for fiscal year 2024. ADVERTISEMENT British pharmaceutical giant AstraZeneca reported earnings that …
2024 Copyright All Right Reserved. @markoflorentino